Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Homoncik

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 10, 2007
Altered platelet plug formation in hyperthyroidism and hypothyroidismMonika Homoncik, Alois Gessl, Arnulf Ferlitsch, et al.
Thrombosis Research|February 15, 2003
Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammationMonika Homoncik, Thomas Pernerstorfer, Rosemarie Reiter, et al.
Transfusion|April 19, 2002
Rapid down modulation of P-selectin glycoprotein ligand-1 (PSGL-1, CD162) by G-CSF in humansBernd Jilma, Nicole Hergovich, Monika Homoncik, et al.
Thrombosis and Haemostasis|February 24, 2006
Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis CWolfgang Sieghart, Monika Homoncik, Bernd Jilma, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 13, 2003
Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expressionMonika Homoncik, Bernd Jilma, Douglas C Donham, et al.
Antiviral Therapy|September 14, 2010
von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4Sibylle Pramhas, Monika Homoncik, Peter Ferenci, et al.
Critical Care Medicine|September 9, 2005
Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascitesArnulf Ferlitsch, Johannes Pleiner, Friedrich Mittermayer, et al.
Molecular & Cellular Proteomics : MCP|August 22, 2007
WITHDRAWN: Extraordinary apolipoprotein oxidation in chronic hepatitis C and liver cirrhosisRaj S Kasthuri, Stephen B Harvey, Matthew D Stone, et al.
The Journal of Infectious Diseases|October 29, 2002
Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammationUrsula M Hollenstein, Thomas Pernerstorfer, Monika Homoncik, et al.
Clinical Pharmacology and Therapeutics|May 16, 2002
Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humansUrsula Hollenstein, Monika Homoncik, Paul Knöbl, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Endocrinology and Metabolism|May 10, 2007
Altered platelet plug formation in hyperthyroidism and hypothyroidismMonika Homoncik, Alois Gessl, Arnulf Ferlitsch, et al.
Thrombosis Research|February 15, 2003
Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammationMonika Homoncik, Thomas Pernerstorfer, Rosemarie Reiter, et al.
Transfusion|April 19, 2002
Rapid down modulation of P-selectin glycoprotein ligand-1 (PSGL-1, CD162) by G-CSF in humansBernd Jilma, Nicole Hergovich, Monika Homoncik, et al.
Thrombosis and Haemostasis|February 24, 2006
Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis CWolfgang Sieghart, Monika Homoncik, Bernd Jilma, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 13, 2003
Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expressionMonika Homoncik, Bernd Jilma, Douglas C Donham, et al.
Antiviral Therapy|September 14, 2010
von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4Sibylle Pramhas, Monika Homoncik, Peter Ferenci, et al.
Critical Care Medicine|September 9, 2005
Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascitesArnulf Ferlitsch, Johannes Pleiner, Friedrich Mittermayer, et al.
Molecular & Cellular Proteomics : MCP|August 22, 2007
WITHDRAWN: Extraordinary apolipoprotein oxidation in chronic hepatitis C and liver cirrhosisRaj S Kasthuri, Stephen B Harvey, Matthew D Stone, et al.
The Journal of Infectious Diseases|October 29, 2002
Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammationUrsula M Hollenstein, Thomas Pernerstorfer, Monika Homoncik, et al.
Clinical Pharmacology and Therapeutics|May 16, 2002
Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humansUrsula Hollenstein, Monika Homoncik, Paul Knöbl, et al.
Pageof 2